No Detail Found!

Bullous pemphigoid treated with dexamethasone-cyclophosphamide pulse therapy

Author(s)
Ramji Gupta Department of Dermatology, Indraprastha Apollo Hospital, SaritaVihar, New Dellhi, India
Abstract
Objective To induce permanent remission in bullous pemphigoid patients. Methods 5 patients of bullous pemphigoid treated with dexamethasone-cyclophosphamide pulse (DCP) therapy are being reported. Diagnosis was confirmed by histopathology and immunofluorescence test. Each pulse comprised of dexamethasone 100 mg dissolved in 500 ml of glucose and transfused intravenously over 1-1.5 hours on three consecutive days. On 2nd day cyclophosphamide 500 mg was transfused through the same drip. It was repeated every 28 days. In between oral cyclophosphamide 50mg daily was given. The whole treatment was divided into 4 phases: phase I, till all the lesions cleared; phase II, no lesions but still DCP was given for 9 months; phase III DCP withdrawn, only oral cyclophosphamide 50mg daily was given for 9 months; and in phase IV, all the treatment was withdrawn and patients are followed-up as much as possible. Period of remission was noted. Results Out of five, three patients entered into remission up to 7.5 years after stoppage of all treatment. Remaining two are in remission for one to two years. Conclusion Dexamethasone-cyclophosphamide pulse therapy is able to induce permanent remission in bullous pemphigoid.
Publication Details
Page(s) 163-167
DOI DOI not available
Published Journal: Journal of Pakistan Association of Dermatologists, Volume: 28, Issue: 2, Year: 2018

Request the full text from PASTIC

Keywords
bullous pemphigoid, dexamethasone-cyclophosphamide pulse therapy
0

Citations

0

Downloads

36

Views